Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors.
Donniacuo M, De Angelis A, Telesca M, Bellocchio G, Riemma MA, Paolisso P, Scisciola L, Cianflone E, Torella D, Castaldo G, Capuano A, Urbanek K, Berrino L, Rossi F, Cappetta D.
Donniacuo M, et al. Among authors: paolisso p.
Pharmacol Res. 2023 Feb;188:106591. doi: 10.1016/j.phrs.2022.106591. Epub 2022 Dec 9.
Pharmacol Res. 2023.
PMID: 36502999
Free article.
Review.